Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEWTREE is a South Korean biotechnology company specializing in the development and commercialization of health functional foods and "inner beauty" products. The company is best known for its proprietary low-molecular-weight collagen peptides, marketed under the brand EverCollagen, which are designed to improve skin health and hydration. NEWTREE utilizes a specialized R&D platform to identify and optimize natural ingredients for various health benefits, including weight management and joint support. As a publicly traded entity on the KOSDAQ, it maintains a significant market presence in the Asian nutraceutical and functional food sectors. The company's business model integrates ingredient discovery, clinical validation, and direct-to-consumer marketing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEWTREE.